Stay updated on SG vs Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.

Latest updates to the SG vs Docetaxel in NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe study record dates were updated with new timestamps (e.g., 2026-04, 2026-04-22, 2026-05-07, 2027-01) and older dates were removed (e.g., 2025-05-23, 2026-01, 2025-05-13, 2025-05). This reflects ongoing maintenance of the EVOKE-01 study record chronology.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, reflecting a minor system/doc build update without changing study information.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed. This appears to be a minor update to the study documents without changing the study design or eligibility.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded Yellowplace, Turkey (Türkiye) as a trial site and removed Sarıyer, Turkey (Türkiye) from the locations list.SummaryDifference0.0%

Stay in the know with updates to SG vs Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.